# LISINOPRIL AND HYDROCHLOROTHIAZIDE
> **ANDA204058** · Abbreviated New Drug Application (Generic) · Sponsor: INVAGEN PHARMS · Approved 2017-05-23
## Drug
- **FDA Application Number:** ANDA204058
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LISINOPRIL AND HYDROCHLOROTHIAZIDE
- **Generic name:** LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS
- **Active ingredients:** HYDROCHLOROTHIAZIDE; LISINOPRIL
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** INVAGEN PHARMS
- **Manufacturer:** Exelan Pharmaceuticals, Inc.
- **First approval:** 2017-05-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204058)
---
*MORVS · CC0 1.0*